Generics Approvals Will Decline, US FDA Predicts, But Supplement Work May Grow

 
• By Derrick Gingery
Generics
Record ANDA supplement receipts pushed predictions of related actions in FY 2020 and FY 2021 to record levels. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics